[1] Gencpinar P, Kocabas A, Duman, et al.Cardiac autonomic dysfunction in patients with Infantile spasm and the effect of adrenocorticotropic hormone treatment [J]. J Child Neurol,2016,31(2):134. [2] Su DJ, Lu JF, Lin LJ, et al.SCN2A mutation in an infant presenting with migrating focal seizures and infantile spasm responsive to a ketogenic diet [J]. Brain Dev,2018,40(8):724-727. [3] Depondt C, Heinzen EL, Goldstein DB.Reply to two patients with TNK2 mutations and late-onset infantile spasm [J]. Ann Neurol,2017,81(1):161. [4] Scantlebury MH, Chun KC, Ma SC, et al.Adrenocorticotropic hormone protects learning and memory function in epileptic kcna1-null mice [J]. Neurosci Lett,2017,645:14-18. [5] Shachor-Meyouhas Y, Ravid S, Hanna S, et al.Legionella pneumophila pneumonia in two infants treated with adrenocorticotropic hormone[J]. J Pediatr,2017,186(7):186-188. [6] Hayashi Y, Yoshinaga H, Akiyama T, et al.Predictive factors for relapse of epileptic spasms after adrenocorticotropic hormone therapy in West syndrome [J]. Brain Dev,2016,38(1):32-39. [7] Chen W, Sheng J, Peng G, et al.Early stage alterations of catecholamine and adrenocorticotropic hormone levels in posttraumatic acute diffuse brain swelling [J]. Brain Res Bull,2017,130(8):47-52. [8] Song JM, Hahn J, Kim SH, et al.Efficacy of treatments for infantile spasms:a systematic review [J]. Clin Neuropharmacol,2017,40(2):63-84. [9] Auvin S, Cilio MR, Vezzani A.Current understanding and neurobiology of epileptic encephalopathies [J]. Neurobiol Dis,2016,92(Pt A):72-89. [10] Kurata H, Terashima H, Nakashima M, et al.Characterization of SPATA5-related encephalopathy in early childhood [J]. Clin Genet,2016,90(5):437-444. [11] Sahu JK, Vaddi VK, Negi S.Review of west syndrome:concerns on optimum dose of adrenocorticotrophic hormone [J]. Clin Drug Investig,2018,38(2):1-2. [12] Mcdonald WC, Banerji N, Mcdonald KN, et al.Steroidogenic factor 1, pit-1, and adrenocorticotropic hormone:a rational starting place for the immuno-histochemical characterization of pituitary adenoma [J]. Arch Pathol Lab Med,2017,141(1):104-112. [13] Shi C, Wang F, Tong A, et al.NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency:a case report and review of literature [J]. Medicine,2016,95(40):e5081. [14] Nhr AC, Shehata MA, Hauser AS, et al.The orphan G protein-coupled receptor GPR139 is activated by the peptides:adrenocorticotropic hormone (ACTH), α-, and β-melanocyte stimulating hormone (α-MSH, and β-MSH), and the conserved core motif HFRW[J]. Neurochem Int,2016,102(1):105-113. [15] Slaats J, Ten Oever J, van de Veerdonk FL, et al.IL-1β/IL-6/CRP and IL-18/ferritin:distinct inflammatory programs in Infections [J]. PLoS Pathog,2016,12(12):e1005973. [16] Oztas B, Sahin D, Kir H, et al.The effect of leptin, ghrelin, and neuropeptide-Y on serum Tnf-Α, IL-1β, IL-6, Fgf-2, galanin levels and oxidative stress in an experimental generalized convulsive seizure model[J]. Neuropeptides,2017,61(2):31-37. [17] Garcia I, Bhullar PK, Tepe B, et al.Local corticotropin releasing hormone (CRH) signals to its receptor CRHR1 during postnatal development of the mouse olfactory bulb [J]. Brain Struct Funct,2016,221(1):1-20. [18] Donner NC, Siebler PH, Johnson DT, et al.Serotonergic systems in the balance:CRHR1 and CRHR2 differentially control stress-induced serotonin synthesis [J]. Psychoneuroendocrinology,2016,63:178-190. [19] Jing Z, Chen Z, Tian J, et al.miR-34b attenuates trauma-induced anxiety-like behavior by targeting CRHR1 [J]. Int J Mol Med,2017,40(1):90-100. [20] Inda C, Pa DSC, Bonfiglio JJ, et al.Different cAMP sou-rces are critically involved in G protein-coupled receptor CRHR1 signaling [J]. J Cell Biol,2016,214 (2):181-195. |